SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018281
Filing Date
2023-11-08
Accepted
2023-11-08 16:16:11
Documents
86
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vstm-20230930x10q.htm   iXBRL 10-Q 1895714
2 EX-31.1 vstm-20230930xex31d1.htm EX-31.1 12985
3 EX-31.2 vstm-20230930xex31d2.htm EX-31.2 13291
4 EX-32.1 vstm-20230930xex32d1.htm EX-32.1 7924
5 EX-32.2 vstm-20230930xex32d2.htm EX-32.2 7962
6 EX-99.1 vstm-20230930xex99d1.htm EX-99.1 270358
7 GRAPHIC vstm-20230930xex99d1001.jpg GRAPHIC 4123
  Complete submission text file 0001558370-23-018281.txt   9044239

Data Files

Seq Description Document Type Size
8 EX-101.SCH vstm-20230930.xsd EX-101.SCH 68778
9 EX-101.CAL vstm-20230930_cal.xml EX-101.CAL 52884
10 EX-101.DEF vstm-20230930_def.xml EX-101.DEF 298978
11 EX-101.LAB vstm-20230930_lab.xml EX-101.LAB 550553
12 EX-101.PRE vstm-20230930_pre.xml EX-101.PRE 451074
80 EXTRACTED XBRL INSTANCE DOCUMENT vstm-20230930x10q_htm.xml XML 1526171
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

IRS No.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 231388111
SIC: 2834 Pharmaceutical Preparations